Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Both mouse and rat models are effective for testing alopecia areata treatments.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

Research on epidermal stem cells has advanced significantly, showing promise for improved clinical therapies.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

A new wearable LED device helps heal chronic infected wounds at home.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

The hair follicle infundibulum plays a key role in skin health and disease, and understanding it better could lead to new skin disease treatments.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

The skin is a complex barrier that protects the body, regulates temperature, and helps with immune responses.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Marie Antoinette syndrome causes sudden hair whitening, but its exact cause is unknown.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

Alefacept showed some effectiveness for alopecia areata but needs more research.

COVID-19 infection may trigger alopecia areata in some patients.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Hair follicles are valuable for regenerative medicine and wound healing.

Hair follicles on the scalp interact with and respond to the nervous system, influencing their own behavior and growth.

Gonadal hormones significantly affect the severity of alopecia areata in mice.